Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab
Ben JACOBS, Ali JAWAD, Zozik FATTAH
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
Keywords: Intestinal perforation; pneumatosis intestinalis; tocilizumab
In this article, we report a case of pneumatosis intestinalis associated with tocilizumab use. This is a unique case and may explain the increased rate of idiopathic bowel perforation among patients taking tocilizumab.
Citation: Jacobs B, Jawad A, Fattah Z. Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab. Arch Rheumatol 2018;33(3):372-375.
The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
The authors received no financial support for the research and/or authorship of this article.